EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Beyond Resectability: Molecular Selection for Salvage Surgery after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Non-Small Cell Lung Cancer

Zurui Liu iD

Journal of Chest Surgery · 05.11.2026 · 59 (6) · 304-305

DOI: 10.5090/jcs.26.115 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Chest Surgery, online erschienen am 12.08.2026. Verfasst von Zurui Liu. Beteiligte Einrichtung: Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.

ORCID-Profile: Zurui Liu

Zitieren

APA

Liu, Z. (2026). Beyond Resectability: Molecular Selection for Salvage Surgery after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Non-Small Cell Lung Cancer. Journal of Chest Surgery, 59(6), 304-305. https://doi.org/10.5090/jcs.26.115

Vancouver

Liu Z. Beyond Resectability: Molecular Selection for Salvage Surgery after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Non-Small Cell Lung Cancer. Journal of Chest Surgery. 2026;59(6):304-305. doi:10.5090/jcs.26.115

BibTeX
@article{Liu2026,
  author = {Liu, Zurui},
  title = {Beyond Resectability: Molecular Selection for Salvage Surgery after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy in Non-Small Cell Lung Cancer},
  journal = {Journal of Chest Surgery},
  year = {2026},
  volume = {59},
  number = {6},
  pages = {304--305},
  doi = {10.5090/jcs.26.115}
}
Kostenlos starten →